IFP Advisors, Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 110 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$3
-100.0%
18
-80.6%
0.00%
Q3 2022$6,000
-14.3%
93
-48.0%
0.00%
Q2 2022$7,0000.0%1790.0%0.00%
Q1 2022$7,000
-75.0%
179
-87.3%
0.00%
-100.0%
Q4 2018$28,000
+3.7%
1,4100.0%0.00%
+100.0%
Q3 2018$27,000
+35.0%
1,410
+7.6%
0.00%0.0%
Q2 2018$20,000
+233.3%
1,310
+322.6%
0.00%
Q1 2018$6,0000.0%3100.0%0.00%
Q4 2017$6,000
-78.6%
310
-80.1%
0.00%
-100.0%
Q3 2017$28,0001,5600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders